Cite Filings / DNLI / 0001714899-21-000018
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Denali Therapeutics Inc. · Filed 2021-02-12 · Acc 0001714899-21-000018

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , dnli-20210212.htm

Around this filing

  • 2021-02-25 8-K Results of operations
  • 2021-02-12 8-K Other events
  • 2021-02-12 SC 13G/A Amended Statement of Ownership
  • 2021-02-11 4 COO and Secretary sold 1,468 shares at an average $74.80 ($109,809)
  • 2021-02-11 4 CFO and Treasurer sold 1,448 shares at an average $74.68 ($108,135)
  • 2021-02-11 4 Chief Medical Officer sold 1,470 shares at an average $74.68 ($109,785)
  • 2021-02-05 8-K Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading dnli-20210212.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…